Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326738 | PMC |
| http://dx.doi.org/10.2340/actadv.v103.6488 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Self-detected Melanomas are Thicker Regardless of Patient's Complexity: A Retrospective Analysis.
Acta Derm Venereol
July 2023
Division of Dermatology, "Santa Chiara" Hospital, Largo Medaglie d'oro 9, IT-38122 Trento, Italy.
Association Between Melanoma Detected During Routine Skin Checks and Mortality.
JAMA Dermatol
December 2021
The Daffodil Centre, The University of Sydney, Cancer Council NSW, Sydney, Australia.
Importance: Early melanoma diagnosis is associated with better health outcomes, but there is insufficient evidence that screening, such as having routine skin checks, reduces mortality.
Objective: To assess melanoma-specific and all-cause mortality associated with melanomas detected through routine skin checks, incidentally or patient detected. A secondary aim was to examine patient, sociodemographic, and clinicopathologic factors associated with different modes of melanoma detection.
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
Trials
May 2021
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Background: Most subsequent new primary or recurrent melanomas might be self-detected if patients are trained to systematically self-examine their skin and have access to timely medical review (patient-led surveillance). Routinely scheduled clinic visits (clinician-led surveillance) is resource-intensive and has not been shown to improve health outcomes; fewer visits may be possible if patient-led surveillance is shown to be safe and effective. The MEL-SELF trial is a randomised controlled trial comparing patient-led surveillance with clinician-led surveillance in people who have been previously treated for localised melanoma.
View Article and Find Full Text PDFEfficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
JAMA Dermatol
May 2021
Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
Importance: A previous single-center study observed fewer excisions, lower health care costs, thinner melanomas, and better quality of life when surveillance of high-risk patients was conducted in a melanoma dermatology clinic with a structured surveillance protocol involving full-body examinations every 6 months aided by total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI).
Objective: To examine longer-term sustainability and expansion of the surveillance program to numerous practices, including a primary care skin cancer clinic setting.
Design, Setting, And Participants: This prospective cohort study recruited 593 participants assessed from 2012 to 2018 as having very high risk of melanoma, with a median of 2.
Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
J Surg Oncol
December 2020
Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Article Synopsis
- Recent advancements in treatment for metastatic melanoma suggest the need to reassess current surveillance practices due to insufficient evidence for existing guidelines, especially in Stage II melanoma.
- A study of Stage II melanoma patients revealed that 27.2% experienced recurrence, primarily detected by patients themselves (60.7%) or through imaging (27.3%).
- Findings indicate that routine imaging is particularly beneficial for detecting distant recurrences in certain patient groups, suggesting its reconsideration in surveillance strategies for high-risk individuals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!